I hope not, but I wouldn't be at all surprised if that happens.  Insurance is a business.  It was interesting to see that the Abbvie combo I am currently on is actually the most effective one for my treatment naïve 1a group.

If I had to choose a treatment, based on what I know now about effectiveness and side effects of this Abbvie combo, I would pick Abbvie. I'm not on any other meds to be worried about possible interactions and I really don't care if I take 5 pills in the am and 4 in the pm as opposed to 1, these side effects are very minor (IMO and so far) and I want my best chance for SVR. 

Thanks LC,

That was an interesting article and comparison. The chart shows how close these protocols truly are in effectiveness. A big improvement to what we just lived through! It's going to be worth watching the providers and their reaction. I hope we don't witness increased limitations to protocols based strictly on price. 

Tig

I had been looking for a chart comparing the current meds, and I ran across one in case anyone else is interested.

http://www.marketwired.com/press-release/move-over-gilead-abbvie-could-bring-serious-competition-to-hcv-market-1956910.htm